Edit |   |
---|---|
Antigenic Specificity | ERBB2/EGFR2/CD340 (Margetuximab biosimilar) |
Clone | monoclonal |
Host Species | Chimeric Human/Mouse |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | Protein A/G purified |
Size | 100 µg, 1 mg, |
Concentration | typically between 0.5-2.0 mg/ml. |
Applications | ELISA, WB |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Margetuximab is a monoclonal antibody biosimilar expressed in CHO cells, targeting ERBB2/EGFR2/CD340, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Margetuximab is under investigation in clinical trial NCT03133988 (Margetuximab Expanded Access Program). |
Immunogen | n/a |
Other Names | Margetuximab, ERBB2/EGFR2/CD340, 1350624-75-7 |
Gene, Accession # | CAS: 1350624-75-7 |
Catalog # | abx831290 |
Price | please inquire |
Order / More Info | ERBB2/EGFR2/CD340 (Margetuximab biosimilar) Antibody from ABBEXA LTD |
Product Specific References | n/a |
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950